Search hospitals > Arizona > Tucson
Arizona Oncology Associates
Claim this profileTucson, Arizona 85704
Global Leader in Cancer
Global Leader in Non-Small Cell Lung Cancer
Conducts research for Breast Cancer
Conducts research for Lung Cancer
Conducts research for Ovarian Cancer
75 reported clinical trials
5 medical researchers
Summary
Arizona Oncology Associates is a medical facility located in Tucson, Arizona. This center is recognized for care of Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Lung Cancer, Ovarian Cancer and other specialties. Arizona Oncology Associates is involved with conducting 75 clinical trials across 87 conditions. There are 5 research doctors associated with this hospital, such as Joseph Buscema, MD, Sudhir Manda, Suresh Mukkamala, MD, and Joesph Buscema, MD.Area of expertise
1Cancer
Global LeaderStage IV
HER2 negative
ER positive
2Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
RECIST 1.1
Top PIs
Joseph Buscema, MDArizona Oncology Associates4 years of reported clinical research
Expert in Ovarian Cancer
Expert in Ovarian Tumors
18 reported clinical trials
32 drugs studied
Sudhir MandaArizona Oncology Associates4 years of reported clinical research
Studies Lymphoma
Studies Colorectal Cancer
17 reported clinical trials
40 drugs studied
Suresh Mukkamala, MDArizona Oncology Associates6 years of reported clinical research
Studies Colorectal Cancer
Studies Tumors
2 reported clinical trials
4 drugs studied
Joesph Buscema, MDArizona Oncology7 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
1 reported clinical trial
6 drugs studied
Clinical Trials running at Arizona Oncology Associates
Cancer
Endometrial Cancer
Microsatellite Instability
Tumors
Solid Tumors
Head and Neck Cancers
Cervical Cancer
Esophageal Cancer
B-Cell Lymphoma
Bladder Cancer
Enfortumab Vedotin
for Advanced Cancer
The primary purpose of this study is to determine the antitumor activity of enfortumab vedotin as measured by confirmed objective response rate (ORR) per RECIST v1.1. This study will also assess other measures of antitumor activity; overall survival (OS); as well as the safety and tolerability of enfortumab vedotin for cohorts 1 to 8 and enfortumab vedotin + pembrolizumab in cohort 9.
Recruiting1 award Phase 210 criteria
MRTX849
for Cancer
This trial is testing a new pill called MRTX849 (adagrasib) for patients with advanced cancers that have a specific genetic change called KRAS G12C. The pill aims to block this change and stop the cancer from growing. Adagrasib is similar to another approved treatment and is intended for patients with this genetic change who have already received other treatments.
Recruiting1 award Phase 1 & 24 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Arizona Oncology Associates?
Arizona Oncology Associates is a medical facility located in Tucson, Arizona. This center is recognized for care of Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Lung Cancer, Ovarian Cancer and other specialties. Arizona Oncology Associates is involved with conducting 75 clinical trials across 87 conditions. There are 5 research doctors associated with this hospital, such as Joseph Buscema, MD, Sudhir Manda, Suresh Mukkamala, MD, and Joesph Buscema, MD.